Tuesday, February 10, 2026
ADVT 
National

519 COVID19 cases for Tuesday

Darpan News Desk BC Government, 15 Feb, 2022 04:54 PM
  • 519 COVID19 cases for Tuesday

As of Tuesday, Feb. 15, 2022, 90.4% (4,506,631) of eligible people five and older in B.C. have received their first dose of COVID-19 vaccine and 85.3% (4,252,281) have received their second dose.

In addition, 93.1% (4,316,016) of eligible people 12 and older in B.C. have received their first dose of COVID-19 vaccine, 90.5% (4,194,522) received their second dose and 53.0% (2,454,932) have received a third dose.

Also, 93.5% (4,042,557) of all eligible adults in B.C. have received their first dose, 90.9% (3,933,436) received their second dose and 55.5% (2,400,288) have received a third dose.

B.C. is reporting 519 new cases of COVID-19, including nine epi-linked cases, for a total of 341,532 cases in the province.

MORE National ARTICLES

Copy-cat fear after Texas synagogue hostage siege

Copy-cat fear after Texas synagogue hostage siege
Toronto police have also increased patrols around synagogues and other Jewish community buildings, although they have said there is no known threat at this time.

Copy-cat fear after Texas synagogue hostage siege

Winter storm pummels large stretch of Ontario

Winter storm pummels large stretch of Ontario
Environment Canada issued snowfall, winter storm or blizzard warnings for a stretch of the province spanning from the Cornwall area to the east, the Algonquin region to the west, and the Niagara and London regions to the south.

Winter storm pummels large stretch of Ontario

China Omicron claim on Canada 'ludicrous': expert

China Omicron claim on Canada 'ludicrous': expert
A Chinese state-controlled news outlet first reported that the Jan. 7 infection of a Beijing resident was the result of receiving a letter or parcel from Canada that passed through Hong Kong.

China Omicron claim on Canada 'ludicrous': expert

Health Canada approves Pfizer COVID-19 drug

Health Canada approves Pfizer COVID-19 drug
The agency authorized Paxlovid for adult patients with mild or moderate COVID-19 who are also at high risk of becoming more seriously ill. Health Canada did not authorize it for use on teenagers or on patients who are already hospitalized because of COVID-19

Health Canada approves Pfizer COVID-19 drug

Pfizer antiviral approved in Canada

Pfizer antiviral approved in Canada
The authorization posted to the Health Canada website Monday morning says the treatment can be used for adult patients with mild or moderate COVID-19 who are also at high risk of becoming more seriously ill.

Pfizer antiviral approved in Canada

Schools open in the West as teachers question plan

Schools open in the West as teachers question plan
Schools in British Columbia and Alberta reopened on Monday with health and education officials stressing the need for in-person learning. Schools in Saskatchewan returned the previous week as scheduled.    

Schools open in the West as teachers question plan